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A B S T R A C T
The 4th Euro-Mediterranean Conference of Natural Products and Drug Discovery: Back to
Mother Nature (BioNat-IV) was recently (fromMarch 3rd through 7th, 2015) convened in Cairo
and Sharm El-Sheikh along the Red Sea coast of Egypt. Overall, the meeting provided a plat-
form for scientists from different nations to discuss emerging ideas that focused on cell
signaling in cancer; the pathogenesis of autoimmune diseases; the identification and use
of natural products as well as novel drug delivery approaches for the treatment of cancer,
arthritis, diabetes, tuberculosis, fungal infection, etc.; and untapped or unconventional sources
for natural products.This fourth in a row conference tried to bridge the gap not only between
basic research and clinical applications, but also between developed nations and develop-
ing countries. With the continuing success of these past meetings, the fifth Euro-
Mediterranean Conference of Natural Products and Drug Discovery (BioNat-V) is slated to
be in February 2017.
© 2016 Production and hosting by Elsevier B.V. on behalf of Shenyang Pharmaceutical
University. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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A natural product is a substance or chemical compound pro-
duced by a living organism that is found in nature. In the
broadest sense, natural products include any substance pro-
duced by life. Natural products can also be replicated by
chemical synthesis (both semisynthesis and total synthesis),
and such undertakings have played a central role in the
development of the field of organic chemistry by taking on chal-
lenging synthetic targets. The term natural product has also
been embraced for commercial purposes to refer to cosmet-
ics, dietary supplements, and foods produced from natural
sources without added artificial ingredients. Within the field
of organic chemistry, the definition of natural products is usually
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restricted to purified organic compounds isolated from natural
sources that are produced via the pathways of primary or sec-
ondary metabolism.
Within the field ofmedicinal chemistry, the definition is often
further restricted to secondary metabolites. Secondary me-
tabolites are not essential for survival, but nevertheless provide
the organisms that produce them with an evolutionary ad-
vantage. Many secondary metabolites are cytotoxic and have
beenselectedandoptimized throughevolution foruseas“chemi-
cal warfare” agents against prey, predators, and competing
organisms. Natural products may possess pharmacological or
biological activity that can be of therapeutic benefit in treat-
ingdiseases.As such,natural products are theactive components
not only of most traditional medicines but also many modern
medicines. Furthermore, because the structural diversity of
natural products exceeds that readily achievable by chemical
synthesis, and synthetic analogs of natural products can be
prepared with improved potency and safety, natural products
are often used as starting points for drug discovery.
Mixtures of plant-derived products are known as botani-
cals, and the term is defined by the United States (US) Food
and Drug Administration (FDA) to describe finished, labeled
products that contain vegetable matter as ingredients, which
can include plant materials, algae,macroscopic fungi, and com-
binations thereof [1]. They can fall under the classification of
a food (including a dietary supplement), a drug (including a
biological drug), a medical device, or a cosmetic [1]. The vast
majority of plant-derived treatments are based on synthetic,
semisynthetic, or otherwise highly purified or chemically modi-
fied drugs [1,2]. According to the most recent report by BCC
Research, the global plant-derived drug market was valued at
US$ 22.1 billion in 2012, and sales are projected to grow to US$
26.6 billion by 2017 at a compound annual growth rate (CAGR)
of 3.8% [3].
Specifically for life, health-driven research is an ideal ob-
jective to aim for. With this in mind, in 2011 five Egyptian
scientists from the City of Scientific Research, Egypt, who pos-
sessed administrative skills, professional experience, research
capabilities and scientific relations/collaborations at local, re-
gional (Arab) and international levels, decided to form the Euro-
MediterraneanAssociation of Life Sciences (EMALS).The primary
aims of EMALS were to contribute effectively to the interna-
tional and national programs of scientific research development,
along with providing strategic services that affect the lives of
scientists, researchers and their assistants, develop their pro-
fessional and research competence, and raise the awareness
of various segments of the society for natural products re-
search and the use of these products for health care. Another
main goal of this Association was to biannually organize a con-
ference series in the Euro-Mediterranean area and invite the
leaders from all over the world to discuss latest develop-
ments in life sciences, drug discovery and cancer research and
other major diseases. Special emphasis and encouragement
are provided to students, and trainees in Egypt and Euro-
Mediterranean are to attend these meetings and to network
with the leaders in their fields.
The purposes of the series of Euro-Mediterranean Confer-
ences of Natural Products and Drug Discovery (BioNat) are to
promote discussion and interaction among academic research-
ers, practitioners, and other professionals in the field of natural
products (metabolic networks, vitamins, carotenoids, flavo-
noids, anti-nutrients, toxins, products of plant-associated
microorganismsandbioactiveproteins).Attention is alsodevoted
to herbalmedicine,plant-derived drugs,phytopharmaceuticals,
synthetic drugs, ethnopharmacology, biodiversity, as well as
research strategies and legislations concerning natural prod-
ucts research.Ultimately, this series of conferenceswill overcome
the challenges of drug discovery and drug delivery in a com-
pletely newway. BioNat hopes to help delegates convert these
expensive, challenging and inefficient processes intomore ac-
cessible and affordable ones.
Planned open panel discussions and breakout sessions on
key thematic areas are effective in energizing the partici-
pants in defining the drug discovery and development
landscape. Several eminent scientists are expected to con-
tinue to attend these conferences, and this will definitely
contribute to advancing the scientific knowledge regarding
natural products. Beside our normal scientific events, attend-
ees have access to a variety of activities covering a large range
of interests.
The first such conference (BioNat-I) was conducted in the
city of Cairo under the title Plant Natural Products from Bio-
diversity to Bioindustry from 8 to 10 December 2009.The themes
of the first meeting were (1) Plant Natural Products as Health
Promoters and Food Additives; (2) Plant Biotechnology; (3) Plant
Biodiversity, Protection and Conservation; (4) Plant Biodiver-
sity & Chemical Ecology; (5) Plant Toxins; (6) Evaluation of Plant
Antioxidant Activities; and (7) Novel Elicitation Strategies & En-
hancing Secondary Metabolite Production in Plants. This
conference was inaugurated by the then President of the Egyp-
tian Academy of Scientific Research, Prof Mahmoud Saker.
The second international conference (BioNat-II) was con-
ducted in the city of Alexandria under the title Natural Products
from Biodiversity to Bioindustry from 11 to 13 December 2011.
The themes of the second meeting were: (1) Biotechnology,
Pharmacology, and Toxicology; (2) Biological Actions; (3) Phy-
tochemistry; (4) Formulations, Applications, Folklore, and
Standardizations; (5) Plant-associated Microorganisms; and (6)
Biodiversity and Conservations. This conference was inaugu-
rated by the Governor of Alexandria, the President of Alexandria
University and the Director of City of Scientific Research.
The third international conference (BioNat-III) was con-
ducted in the city of Cairo under the title Natural Products from
Biotechnology to NanoMedicine from 4 to 7 January 2013. The
topics covered in BioNat-III were (1) Stability and Efficacy of
Natural Products; (2) Biotechnology and Molecular Biology; (3)
ModeofActionofNatural Products; (4) Pharmacogenomics,Phar-
macodynamics and Pharmacokinetics; (5) Nanoformulations,
Nanoparticle Delivery and Nanotoxicology; (6) Pharmacology,
Toxicology and BiologicalActions; and (7) RiskAssessment, For-
mulations, Applications & Standardizations.
The fourth international conference titled Natural Prod-
ucts and Drug Discovery was convened in Sharm El-Sheikh,
March 3–7, 2015. Long before the first foreign tourists dived
beneath Sharm el Sheikh’s crystal blue waters, this popular
holiday destination was one of Egypt’s most significant ports.
Located at the southern tip of the Sinai Peninsula, where the
Red Sea meets the Gulf of Suez and the Gulf of Aqaba, Sharm
el Sheikh has grown from a sleepy fishing village where 100
Bedouins lived just 40 years ago, into a major touristic hotspot
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and resort city in Egypt. Sharm el Sheikh has and continues
to be called the “City of Peace,” referring to the large number
of international peace conferences that have been held there.
The most historical chapter of Sharm el Sheikh is said to have
taken place in Jabal Musa (Mount Sinai), where, in Biblical times,
Moses is believed to have climbed the mountain and re-
ceived two tablets upon which the Ten Commandments were
inscribed. Another important Biblical landmark situated near
Sharm el Sheikh is St. Catherine’s Monastery, which dates all
the way back to the 4th century BC and is widely acknowl-
edged as being the site of the Burning Bush.
About 150 scientists from more than 15 nations gathered
in the City of Peace to discuss natural products and drug dis-
covery. During recent years, it has been recognized that
identification of pathways that lead to the maintenance, sur-
vival, and/or proliferation of tumor tissue is needed to
understand the pathophysiology of the disease, and importantly
to identify druggable targets based on this pathophysiology.
Drugs, such as Gleevec, which targets the biology of the disease,
has become the poster child of how cancer could be treated,
controlled, or cured. The objective of the 3-day conference
(BioNat-IV) was to bring together laboratory and clinical sci-
entists from developed and developing nations to share current
knowledge and future strategies for drug discovery and to en-
lighten the chemistry of natural products. The format of the
meeting was the daily main conference, parallel mini sympo-
sia, and poster sessions.
Prof. Dr. Ahmad M H Shaban, the vice president of the Na-
tional Research Center (NRC), inaugurated the meeting in
Cairo and emphasized the importance of research in natural
products and medicinal plants, particularly for controlling
cancer. Prof Dr. Ashraf Khalil (City of Scientific Research, Borg
Elarab, Egypt) chaired the first session on Natural and Chemi-
cal Prevention of Cancer. Dr. Hassan Mukhtar (Wisconsin
University) set the scientific stage with his keynote speech
that focused on his journey of targeted cancer therapy with
nanoencapsulation of natural products. He reviewed 25 years
of molecular medicine that evolved from oncogenomics. He
has been instrumental in developing novel targeted therapeu-
tics. His presentation also emphasized that while targets could
be identified and specific drugs could be developed, in many
cases resistance develops to the therapy, which poses new
challenges. In another keynote lecture, Dr. Kamal D. Moudgil
(University of Maryland School of Medicine, Baltimore, USA)
discussed Celastrus as an example of Chinese herbs, which
have been used in traditional Chinese medicine for centuries
for the treatment of inflammatory and other diseases, that
can control autoimmune arthritis by altering proinflammatory
cytokines and T helper 17 (Th17; pathogenic cells)/T regula-
tory (Treg; protective cells) balance.
The afternoon session on the first day was devoted to one
plenary lecture and three oral presentations. In a plenary lecture,
Dr. Mohammed A Ramadan (Cairo University, Egypt) pre-
sented the results of his first report on antimycobacterial activity
of the Egyptian Euphorbia paralias plant and explained its im-
portance as a promising source for antimycobacterial drugs.
Dr. Hanan Alashaal (Pharmaceutical and Drug Industries Re-
search Division, NRC) gave an oral presentation on the
development of antidiabetic drugs from natural resources using
the plant cell and tissue culture biotechnology.This application
was based on her results on the evaluation and in vitro pro-
duction of oral hypoglycemic agents synthesized from Solanum
and Balanities aegyptiaca plants. Also, Dr. Ahmed M Alzohairy
gave an oral presentation on the comparative assessments of
the genotype, chemical composition and biological activities
of three different Moringa species in Egypt. Finally, Dr. Hisham
El-Shoky (Agriculture Research Center, Egypt) concluded in his
presentation that the in vitro confocal microscopy of SeNPs and
PEGlated SeNPs confirmed the intracellular delivery of
nanoparticles by endocytosis. In his experimental system, PEG-
SeNPs were uptaken and diffused into the Caco-2 cells within
3 hours. Also, PEG-SeNPs exhibited dose-dependent growth
inhibition.
By the dawn of the second day, the whole BioNat-IV group
traveled to a lovely resort along the bay of Sharm El-Sheikh.
The agenda of the conference was rich and informative. The
attendees participated in nine different scientific sessions that
focused on various themes in anticancer drug discovery, anti-
infectives, cardiovascular drug discovery, CNS drug discovery,
diabetes and obesity drug discovery, drug delivery, target iden-
tification and validation, chemistry of natural products and
computational approaches and bioinformatics. Every session
was introduced by a chairperson presenting an overview of the
topic, opportunities to intervene, and challenges confronted.
The first session in Sharm El-Sheikh was introduced by Dr.
Kamal Moudgil (University of Maryland School of Medicine,
USA), and many important topics were discussed by several
speakers in that session.
Dr. Larysa M Skivka (Taras Shevchenko Kyiv National Uni-
versity, Ukraine) focused on circadian control of metabolic
polarization and drug sensitivity of circulating granulocytes in
healthy men. While Dr. Irina Camilia CHIS (University of
Medicine and Pharmacy “Iuliu Hat¸ieganu,” Romania) re-
ported that oral supplementation of Quercetin to trained
diabetic rats restored endothelial function and NO bioavailability
and significantly restored lipid peroxidation and protein
carbonylation markers to near normal in the thoracic aorta.
Based on these findings, she suggested that Quercetin treat-
ment in association with chronic moderate exercise reverses
vascular endothelial dysfunction in diabetic rats.
On the third day, the morning session was chaired by Dr.
HishamAl-Askary (Faculty of Pharmacy, Cairo University, Egypt).
The keynote presentation for the session was by Dr. Mohamed
Hassanein (Biochemistry Department, Zagazig University, Egypt).
His research and presentation was focused on bioactive lipids
from unconventional sources. He spotlighted the effects of fatty
acids and bioactive lipids on physiological functions of the
human body, and the role of oilseeds and phenolipids as a new
generation of natural antioxidants with improved bioavailability.
Additional major presentations in this session from Drs.
Sadish Kumar (Paramedical College (Pharmacy), Ghaziabad,
India) and Salwa Mohamed Khogali (Pharmacology Central of
Veterinary Research, Sudan) centered on the path that may lead
to the discovery of many drugs from algae and fruits of the
plants.These scientists concurred that natural products could
act as potential drugs to target inflammation and cancer.
The final session on the last day was devoted to a story of
success presented by Dr Kamal D Moudgil. He spoke about his
research interests which focused on two areas: first, the in-
duction and regulation of autoimmunity; and second, antigen
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processing and presentation. His studies are based on the rat
adjuvant arthritis (AA) model of human rheumatoid arthritis
(RA). He also shared a lot of his scientific experience with the
conference participants on how to navigate their profes-
sional career during and after graduate studies leading to their
first job as a scientist in academia or industry. He offered an-
ecdotes from his own experience and that of others he was
aware of in overcoming any problems that they faced as they
worked to achieve their goals.
The poster sessions were chaired by Dr Mona M Marzouk
(NRC, Egypt) and Dr.Mona Kassem (NRC, Egypt), withmore than
60 posters competing in a fair contest and cozy atmosphere.
Dr.Alaadin E. El-Haddad (Department of Pharmacognosy, Faculty
of Pharmacy, University of 6th October, Egypt) presented a poster
on antihyperglycemic activity and nitrile glycosides of Moringa
peregrina (Forssk.) seeds. Dr. Walaa H Salama (Department of
Molecular Biology, NRC, Egypt) presented a poster on methods
of purification and biochemical characterization of thermoactive
L-amino acid oxidase isozymes from Egyptian horned viper
venom. Dr Ashraf A Khalil presented a poster on enhance-
ment of mechanical properties, microstructure and
antimicrobial activities of zein films cross-linked using suc-
cinic anhydride, eugenol, and citric acid [4,5]. Dr.MahaM Salama
(Department of Pharmacognosy, Faculty of Pharmacy, Cairo Uni-
versity, Egypt) presented a poster on antiprotozoal activity of
the major constituents from the bioactive fraction of Verbesina
encelioides. Amira A Abdellatef (Institute of Genetic Engineer-
ing and Biotechnology, City of Scientific Research, Borg Elarab,
Alexandria, Egypt) presented a poster on lactic acid bacteria
as antimycotic and antimycotoxin agents against toxigenic Fu-
sarium species associated with maize grains stored/sold in
Egyptian markets [6,7]. Mariia P. Rudyk (Department of Micro-
biology and General Immunology, Educational and Scientific
Centre, Institute of Biology, Taras Shevchenko National Uni-
versity of Kyiv, Ukraine) presented interesting work on circadian
control of metabolic polarization and drug sensitivity of cir-
culating granulocytes in healthy men.
After the final evaluation of all presented posters, the poster
presented by Dr. Shahira M Ezzat (Faculty of Pharmacy, Cairo
University, Egypt) won the Award for the Best Poster. Her work
was on hepatoprotective activity and UPLC-qTOF-PDA-MS profile
of the anthocyanins of Hibiscus sabdariffa L. epicalyses.A couple
of Complimentary Best Poster Awards were granted to Dr Mai
M. Raslan (Faculty of Post Graduate Studies for Advanced Sci-
ences, Beni-Suef University, Egypt) and Dr. Maha M Salama
(Faculty of Pharmacy, Cairo University, Egypt).
Close to 25 presentations were concentrated on drug dis-
covery and therapeutics, including natural products. The
conference provided opportunities for young scientists and local
scientists from Egypt to present their work to an international
audience and discuss research work of mutual interest.
Similarly, more than 60 students, fellows, and other trainees
participated in two poster sessions that were attended by all
participants. Please visit the website [8] to review previousmeet-
ings and to obtain updates and additional information for future
BioNat conferences.
With the continuing success of these meetings, the fifth
Euro-Mediterranean Conference of Natural Products and Drug
Discovery (BioNat-V) is slated for February 2017. Please contact
us if you are interested in participating, presenting, or sup-
porting the next conference.
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